Cargando…

Publisher Correction to: Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Publisher Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098942/ https://www.ncbi.nlm.nih.gov/pubmed/31950254 http://dx.doi.org/10.1007/s00392-019-01582-z

Ejemplares similares

Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction
por: Rørth, Rasmus, et al.
Publicado: (2019)

Mortality outcome and predictive risk factors for death in patients with heart failure and reduced ejection fraction who declined implantable cardioverter defibrillator implantation in Singapore
por: Khoo, Chun Yuan, et al.
Publicado: (2018)

Feasibility and First Results of Heart Failure Monitoring Using the Wearable Cardioverter–Defibrillator in Newly Diagnosed Heart Failure with Reduced Ejection Fraction
por: Hillmann, Henrike Aenne Katrin, et al.
Publicado: (2021)

Publisher Correction to: Electrocardiogram-less, free-breathing myocardial extracellular volume fraction mapping in small animals at high heart rates using motion-resolved cardiovascular magnetic resonance multitasking: a feasibility study in a heart failure with preserved ejection fraction rat model
por: Han, Pei, et al.
Publicado: (2021)

Impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for implantable cardioverter defibrillators
por: Joshi, Subodh B, et al.
Publicado: (2011)

Magnetic Resonance Assessment of Ejection Fraction Versus Echocardiography for Cardioverter-Defibrillator Implantation Eligibility
por: Schiau, Călin, et al.
Publicado: (2021)

Selection of patients eligible for implantable cardioverter defibrillator: beyond left ventricular ejection fraction
por: Rizzello, Vittoria
Publicado: (2022)

Predictors for early mortality in patients with implantable cardiac defibrillator for heart failure with reduced ejection fraction
por: Çinier, Göksel, et al.
Publicado: (2022)

Correction to: Dapaglifozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
por: Blair, Hannah A.
Publicado: (2021)

Publisher Correction: Microwave photons emitted by fractionally charged quasiparticles
por: Bisognin, R., et al.
Publicado: (2019)

Predictors of primary prevention implantable cardioverter‐defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all‐cause mortality
por: Schrage, Benedikt, et al.
Publicado: (2022)

Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator—The PROLONG Study
por: Duncker, David, et al.
Publicado: (2017)

Potential clinical impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for cardioverter defibrillator implantation
por: Joshi, Subodh B, et al.
Publicado: (2012)

Heart rate in patients with reduced ejection fraction: relationship between single time point measurement and mean heart rate on prolonged implantable cardioverter defibrillator monitoring
por: Habal, Marlena V., et al.
Publicado: (2018)

Publisher Correction: MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure
por: Dubois-Deruy, Emilie, et al.
Publicado: (2018)

Assessment of heart failure parameters by telemonitoring patients with an implantable cardioverter defibrillator
por: Fily, M, et al.
Publicado: (2022)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Publisher Correction: The Value of Cardiopulmonary Exercise Testing in Determining Severity in Patients with both Systolic Heart Failure and COPD
por: da Luz Goulart, Cássia, et al.
Publicado: (2020)

Implantable cardioverter-defibrillators in congenital heart disease
por: Chubb, H., et al.
Publicado: (2016)

Correction to: Structural and myocardial dysfunction in heart failure beyond ejection fraction
por: Severino, Paolo, et al.
Publicado: (2019)

Publisher Correction: Publisher correction for multiple articles
Publicado: (2022)

Publisher Correction: Measuring the ionisation fraction in a jet from a massive protostar
por: Fedriani, R., et al.
Publicado: (2019)

Association between implanted cardioverter-defibrillators and mortality for patients with left ventricular ejection fraction between 30% and 35%
por: Wasfy, Jason H, et al.
Publicado: (2023)

Correction: Risk factors for incident heart failure with preserved or reduced ejection fraction, and valvular heart failure, in a community-based cohort
Publicado: (2018)

Publisher Correction: In vitro investigation of chemical properties and biocompatibility of neurovascular braided implants
por: Cattaneo, Giorgio, et al.
Publicado: (2020)

Publisher Correction: Human heart-forming organoids recapitulate early heart and foregut development
por: Drakhlis, Lika, et al.
Publicado: (2021)

Deactivation of implantable cardioverter defibrillator in Japanese patients with end‐stage heart failure
por: Nakazawa, Mayui, et al.
Publicado: (2020)

Depressive Symptoms and Quality of Life in Patients With Heart Failure and an Implantable Cardioverter-Defibrillator
por: Zormpas, Christos, et al.
Publicado: (2022)

Causes of Failure to Capture in Pacemakers and Implantable Cardioverter-defibrillators
por: Sabbagh, Ebrahim, et al.
Publicado: (2020)

Comorbid Hypertension Reduces the Risk of Ventricular Arrhythmia in Chronic Heart Failure Patients with Implantable Cardioverter-Defibrillators
por: Huang, Hao, et al.
Publicado: (2022)

Publisher Correction: Pluripotent stem cell-derived model of the post-implantation human embryo
por: Weatherbee, Bailey A. T., et al.
Publicado: (2023)

Implantable Cardioverter-defibrillators in Adult Congenital Heart Disease
por: Stewart, Merrill H., et al.
Publicado: (2018)

Implantable Cardioverter-Defibrillator Lead in an Explanted Human Heart
por: Jeong, Hyung Ki, et al.
Publicado: (2022)

Relationship between right and left ventricular function in candidates for implantable cardioverter defibrillator with low left ventricular ejection fraction
por: Jimenez-Juan, Laura, et al.
Publicado: (2017)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

The Effect of Sacubitril/Valsartan on Device Detected Arrhythmias and Electrical Parameters among Dilated Cardiomyopathy Patients with Reduced Ejection Fraction and Implantable Cardioverter Defibrillator
por: Russo, Vincenzo, et al.
Publicado: (2020)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Publisher Correction: Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity
por: Stone, Will J. R., et al.
Publicado: (2018)

Publisher Correction: Demonstration of reduced neoclassical energy transport in Wendelstein 7-X
por: Beidler, C. D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ag56t26pr43skbsq32not7nco5